Metabolic and Bariatric Surgery Utilization in the Era of Glucagon-Like Peptide-1 Receptor Agonists among Adolescents versus Adults

J Pediatr. 2025 Jul:282:114564. doi: 10.1016/j.jpeds.2025.114564. Epub 2025 Mar 23.

Abstract

This cross-sectional study analyzed adolescent metabolic and bariatric surgery (MBS) utilization before and after glucagon-like peptide-1 receptor agonist (GLP-1RA) medication approval, comparing trends across race and ethnic groups. Although both MBS and GLP-1RA are effective weight management strategies, adolescent MBS utilization increased, while adult rates declined from 2021 through 2023.

Keywords: adolescents; adults; bariatric surgery; prevalence.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Bariatric Surgery* / statistics & numerical data
  • Bariatric Surgery* / trends
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Humans
  • Male
  • Young Adult

Substances

  • Glucagon-Like Peptide-1 Receptor Agonists